NeoBiocon partners with Novartis
To offer Vildagliptin for diabetics in the UAE
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Wockhardt receives QIDP status from US FDA
WCK 5222 is a new class of antibiotic for gram negative terrain for complicated urinary tract infections and HABP/ VABP
Wockhardt…
Hetero receives DCG(I) approval for fixed-dose combination therapy ‘Ledipasvir-Sofosbuvir’
The product will be available under the brand name ‘Ledisof’ in India
Pharmexcil discusses pharma export issues in COA meeting
Ministry to discuss impact of TPP on pharma sector in Jan or Feb
In order to increase pharmaceutical exports and resolve various…
EMA accepts Sandoz application for biosim etanercept
The EMA's acceptance follows recent US FDA regulatory submission acceptance
Global SME partnerships needed for success of ‘Make in India’ initiative: Kalraj Mishra
The minister also launched CII’s new SME initiative
DRL signs MoU with LSSSDC and VIPER
The MoU is aimed at fostering market research collaboration that will help align educational courses to industry requirements
21st Anniversary Special Issue
With health at the core of several initiatives driven by the Centre, how can we translate political rhetoric into sustainable…
Gilead Sciences keen to set up unit in Hyderabad
The unit is likely to come up in proposed 'Pharma City'
Global GVHD treatment market will thrive, reaching $545 million by 2023
The report also states that Roche’s Rituxan has emerged as the most clinically and commercially attractive therapy that is used in…